Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

The new firm is raising a $150 million fund to back startups around science emerging outside Boston and San Francisco.

BMO Capital Markets managing director of biopharma equity research Evan Seigerman joins Market Domination to discuss the best ...

CARSON CITY, NV, Sept. 19, 2024 (GLOBE NEWSWIRE) -- (OTC PINKS: PHBI) ("Pharmagreen" or the "Company") is pleased to announce ...

Discover why Inhibrx is a hidden gem in biotech, poised for major growth with innovative treatments. For more investment ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Biotech Nuvalent unveiled updates on two experimental cancer medicines over the weekend. Analysts say each could be the best ...

We recently published a list of 10 Worst Booming Stocks to Buy According to Short Sellers. In this article, we are going to ...

GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...

The drop in interest rate is slightly bigger than anticipated and good news for the biotech industry, but little will change ...

A rather odd week in venture, as the biggest rounds were raised by greentech, business travel and charity startups. Of course ...

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...